The RhoA GTPase inhibitors simvastatin or Rhosin and the YAP1 inhibitors verteporfin or CA3 significantly inhibited the proliferation and colony formation abilities of ANLN-overexpressing ICC cells (Fig. 7H, I and Supplementary Fig. S9C, D). The gene discussed is RHOA; the disease is intrahepatic cholangiocarcinoma.